Google scoops up another high-profile scientist for anti-death project
Above: New Calico recruit Dr. Cynthia Kenyon.
Image Credit: UCSF Kenyon Lab
April 20, 2014 12:11 PM
Dylan Tweney
356
1.3k
141
189
17
2
Google’s secretive Project Calico is aimed at defeating death itself — or at least staving it off far longer than ever before.
To that end, the company has been recruiting some of the top names in anti-aging and genetics research. The latest is Cynthia Kenyon, a high-profile biochemist and biophysicist at the University of California, San Francisco, according to a report in the San Francisco Chronicle.
VentureBeat actually reported in November that Kenyon would be joining Calico; she has served as a consultant to the project since then. The Chronicle confirmed that she has finally left her UCSF post to join Calico full time, although she’ll retain the title of professor emeritus at UCSF.
Kenyon’s UCSF lab has focused its research since the 1990s on a small roundworm, C. elegans. Kenyon’s team found that modifications to a gene called daf-2 resulted in doubling the lifespan of the worms, from two weeks to four; another gene, daf-16, kept them youthful despite their extended ages.
“Seeing them is like being with someone that looks 40 and learning that they are really 80,” the lab notes on its website.
Subsequent research, by other scientists, have shown that similar genes control lifespan and aging in fruit flies, mice, and possibly even humans. Changing the genes slows aging and increases resistance to age-related diseases such as cancer, heart failure, and protein-aggregation disease.
In coming to Calico, Kenyon joins former Genentech chief executive and current Calico CEO Arthur Levinson; former Roche chief medical officer Hal Barron; Robert Cohen, a senior oncologist at Genentech; and David Botstein, the former director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University.
It’s an A-team of genetics researchers that reflects the magnetism that Google’s powerful vision (and cash) exerts. Whether the team will be able to accomplish things where others have failed is still uncertain. Few details on what exactly Calico is doing have emerged, apart from Google founder Larry Page’s initial post on the project and Levinson’s bland “it’s great to be part of the team” note from September.
In December, VentureBeat called Calico “the most interesting startup in Silicon Valley.
Google scoops up another high-profile scientist for anti-death project | VentureBeat | Health | by Dylan Tweney
----------------------
Anti-death project?
Google is fukking with the afterlife too
Above: New Calico recruit Dr. Cynthia Kenyon.
Image Credit: UCSF Kenyon Lab
April 20, 2014 12:11 PM
Dylan Tweney
356
1.3k
141
189
17
2
Google’s secretive Project Calico is aimed at defeating death itself — or at least staving it off far longer than ever before.
To that end, the company has been recruiting some of the top names in anti-aging and genetics research. The latest is Cynthia Kenyon, a high-profile biochemist and biophysicist at the University of California, San Francisco, according to a report in the San Francisco Chronicle.
VentureBeat actually reported in November that Kenyon would be joining Calico; she has served as a consultant to the project since then. The Chronicle confirmed that she has finally left her UCSF post to join Calico full time, although she’ll retain the title of professor emeritus at UCSF.
Kenyon’s UCSF lab has focused its research since the 1990s on a small roundworm, C. elegans. Kenyon’s team found that modifications to a gene called daf-2 resulted in doubling the lifespan of the worms, from two weeks to four; another gene, daf-16, kept them youthful despite their extended ages.
“Seeing them is like being with someone that looks 40 and learning that they are really 80,” the lab notes on its website.
Subsequent research, by other scientists, have shown that similar genes control lifespan and aging in fruit flies, mice, and possibly even humans. Changing the genes slows aging and increases resistance to age-related diseases such as cancer, heart failure, and protein-aggregation disease.
In coming to Calico, Kenyon joins former Genentech chief executive and current Calico CEO Arthur Levinson; former Roche chief medical officer Hal Barron; Robert Cohen, a senior oncologist at Genentech; and David Botstein, the former director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University.
It’s an A-team of genetics researchers that reflects the magnetism that Google’s powerful vision (and cash) exerts. Whether the team will be able to accomplish things where others have failed is still uncertain. Few details on what exactly Calico is doing have emerged, apart from Google founder Larry Page’s initial post on the project and Levinson’s bland “it’s great to be part of the team” note from September.
In December, VentureBeat called Calico “the most interesting startup in Silicon Valley.
Google scoops up another high-profile scientist for anti-death project | VentureBeat | Health | by Dylan Tweney
----------------------
Anti-death project?
Google is fukking with the afterlife too
whats next?
And so it begins
